Serum Institute of India

More than half of the adult population has yet to receive even a single dose, despite a slight improvement in coverage in July

As against 86 lakh doses that need to be administered per day, the vaccination rate has been just 40 lakh a day over the past week

The Centre must speed up negotiations with foreign companies towards the removal of stumbling blocks to expand coverage

"Excited to witness the first batch of Covovax (developed by @Novavax) being manufactured this week at our facility in Pune," he shared in a tweet on Friday.

These 44 crore doses of COVID-19 vaccines will be delivered by their makers between August and December 2021, the Union Health Ministry said.

As per BSE block deal data, Poonawalla sold 31,57,034 scrips he held in the firm at a price of Rs 373.85 per share.

Task Force also discussed with them various alternatives to drugs that are in high demand like Remdesivir

India rolled out the third phase of its COVID-19 vaccination drive for those in the age group of 18-45 years on Saturday.

A million doses from the institute, which had already been delivered, have been sold on to other countries in the African Union.

Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India. It has been tested against African and UK variants of COVID19 and has an overall efficacy of 89 per cent.

Thailand last week was the first country outside Europe to temporarily suspend using the AstraZeneca vaccine.

Both SII and Bharat Biotech are involved in producing Covid-19 vaccine

However, the union health ministry would take a final call on the proposition.

The West African nation of 30 million has recorded 81,245 cases and 584 deaths since the beginning of the pandemic, according to figures from Ghana's Health Services on Tuesday.

The coronavirus has infected more than 109 million people and killed at least 2.4 million of them.